WD-910

N/A

Report date: 2025/04/20 20:00:03

Base Information

Drug NameWD-910
Drug Alias NameWD-910
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsDementiaMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesNingbo Wenda Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNingbo Wenda Pharma
Inactive CompaniesN/A
Active IndicationsDementiaMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A